Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial
Investigational New Drugs · 2024
DOI: 10.1007/s10637-024-01481-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigational New Drugs, 2024. Verfasst von Mathilde Morisseau und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud- IUCT-O, 1 Avenue Irène Joliot-Curie, Toulouse, Cedex 9, 31059, France. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Bristol-Myers Squibb Foundation for Research in Immuno-Oncology.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud- IUCT-O, 1 Avenue Irène Joliot-Curie, Toulouse, Cedex 9, 31059, France.
- Department of Medical Oncology, Oncopole Claudius Regaud- IUCT-O, Toulouse, France.
- Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Montpellier, France.
- Department of Pneumology, CHU Toulouse Larrey, Toulouse, France.
- Department of Medical Oncology, Institut Curie, Paris, Saint-Cloud, France.
- Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France.
Förderung
- Bristol-Myers Squibb Foundation for Research in Immuno-Oncology
Zitieren
APA
Morisseau, M., Gomez-Roca, C., Viala, M., Rabeau, A., Loirat, D., Munsch, N., Thomas, K., Pages, C., Korakis, I., Sibaud, V., Delord, J. P., Filleron, T., & Cabarrou, B. (2024). Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial. Investigational New Drugs. https://doi.org/10.1007/s10637-024-01481-9
Vancouver
Morisseau M, Gomez-Roca C, Viala M, Rabeau A, Loirat D, Munsch N, et al. Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial. Investigational New Drugs. 2024. doi:10.1007/s10637-024-01481-9
BibTeX
@article{Morisseau2024,
author = {Morisseau, Mathilde and Gomez-Roca, Carlos and Viala, Marie and Rabeau, Audrey and Loirat, Delphine and Munsch, Nadia and Thomas, Kristell and Pages, Cécile and Korakis, Iphigenie and Sibaud, Vincent and Delord, Jean-Pierre and Filleron, Thomas and Cabarrou, Bastien},
title = {Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial},
journal = {Investigational New Drugs},
year = {2024},
doi = {10.1007/s10637-024-01481-9}
}
EUVIMED